Literature DB >> 26680205

The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus Infection.

Aaron S Rapaport1, Jill Schriewer2, Susan Gilfillan1, Ed Hembrador2, Ryan Crump2, Beatrice F Plougastel3, Yaming Wang1, Gaelle Le Friec1, Jian Gao3, Marina Cella1, Hanspeter Pircher4, Wayne M Yokoyama5, R Mark L Buller2, Marco Colonna6.   

Abstract

CD8(+) T cells and NK cells protect from viral infections by killing virally infected cells and secreting interferon-γ. Several inhibitory receptors limit the magnitude and duration of these anti-viral responses. NKG2A, which is encoded by Klrc1, is a lectin-like inhibitory receptor that is expressed as a heterodimer with CD94 on NK cells and activated CD8(+) T cells. Previous studies on the impact of CD94/NKG2A heterodimers on anti-viral responses have yielded contrasting results and the in vivo function of NKG2A remains unclear. Here, we generated Klrc1(-/-) mice and found that NKG2A is selectively required for resistance to ectromelia virus (ECTV). NKG2A functions intrinsically within ECTV-specific CD8(+) T cells to limit excessive activation, prevent apoptosis, and preserve the specific CD8(+) T cell response. Thus, although inhibitory receptors often cause T cell exhaustion and viral spreading during chronic viral infections, NKG2A optimizes CD8(+) T cell responses during an acute poxvirus infection.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8(+) T cell; NK cell; NKG2A; cytokine; inhibitory receptor; virus

Mesh:

Substances:

Year:  2015        PMID: 26680205      PMCID: PMC4745883          DOI: 10.1016/j.immuni.2015.11.005

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  39 in total

1.  The structural basis for intramembrane assembly of an activating immunoreceptor complex.

Authors:  Matthew E Call; Kai W Wucherpfennig; James J Chou
Journal:  Nat Immunol       Date:  2010-10-03       Impact factor: 25.606

2.  Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

Authors:  Linrong Lu; Koichi Ikizawa; Dan Hu; Miriam B F Werneck; Kai W Wucherpfennig; Harvey Cantor
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

3.  Lack of CD200 enhances pathological T cell responses during influenza infection.

Authors:  Tomasz P Rygiel; Eva S K Rijkers; Talitha de Ruiter; Ellen H Stolte; Martin van der Valk; Guus F Rimmelzwaan; Louis Boon; Anton M van Loon; Frank E Coenjaerts; Robert M Hoek; Kiki Tesselaar; Linde Meyaard
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

4.  Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis.

Authors:  Stephen N Waggoner; Ruth T Taniguchi; Porunelloor A Mathew; Vinay Kumar; Raymond M Welsh
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

5.  Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.

Authors:  Per C Saether; Sigurd E Hoelsbrekken; Sigbjørn Fossum; Erik Dissen
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

6.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

Review 7.  Expansion, maintenance, and memory in NK and T cells during viral infections: responding to pressures for defense and regulation.

Authors:  Christine A Biron
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

8.  NKG2A inhibits invariant NKT cell activation in hepatic injury.

Authors:  Toshihiko Kawamura; Kazuyoshi Takeda; Hiroshi Kaneda; Hiroaki Matsumoto; Yoshihiro Hayakawa; David H Raulet; Yoshinori Ikarashi; Mitchell Kronenberg; Hideo Yagita; Katsuyuki Kinoshita; Toru Abo; Ko Okumura; Mark J Smyth
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.

Authors:  Lucy C Sullivan; Craig S Clements; Travis Beddoe; Darryl Johnson; Hilary L Hoare; Jie Lin; Trevor Huyton; Emma J Hopkins; Hugh H Reid; Matthew C J Wilce; Juraj Kabat; Francisco Borrego; John E Coligan; Jamie Rossjohn; Andrew G Brooks
Journal:  Immunity       Date:  2007-12       Impact factor: 31.745

10.  CD94 is essential for NK cell-mediated resistance to a lethal viral disease.

Authors:  Min Fang; Mark T Orr; Pieter Spee; Thomas Egebjerg; Lewis L Lanier; Luis J Sigal
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

View more
  31 in total

1.  NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

Authors:  Nadine van Montfoort; Linda Borst; Michael J Korrer; Marjolein Sluijter; Koen A Marijt; Saskia J Santegoets; Vanessa J van Ham; Ilina Ehsan; Pornpimol Charoentong; Pascale André; Nicolai Wagtmann; Marij J P Welters; Young J Kim; Sytse J Piersma; Sjoerd H van der Burg; Thorbald van Hall
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

2.  Evidence of functional Cd94 polymorphism in a free-living house mouse population.

Authors:  Linn E Knutsen; Erik Dissen; Per C Saether; Elisabeth Gyllensten Bjørnsen; Jaroslav Piálek; Anne K Storset; Preben Boysen
Journal:  Immunogenetics       Date:  2018-12-10       Impact factor: 2.846

3.  Chronic Lymphocytic Choriomeningitis Infection Causes Susceptibility to Mousepox and Impairs Natural Killer Cell Maturation and Function.

Authors:  Pedro Alves-Peixoto; Maria Férez; Cory J Knudson; Colby Stotesbury; Carolina R Melo-Silva; Eric B Wong; Margarida Correia-Neves; Luis J Sigal
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

4.  Ly49R activation receptor drives self-MHC-educated NK cell immunity against cytomegalovirus infection.

Authors:  Awndre Gamache; John M Cronk; William T Nash; Patryk Puchalski; Alyssa Gillespie; Hairong Wei; Laurie Gray; Marie-Louise Hammarskjold; Wenhao Xu; Michael G Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

5.  Editorial: On matters of maturity, self-control, and responsiveness: inhibitory NK receptors in the driver's seat?

Authors:  Michael G Brown; Awndre Gamache
Journal:  J Leukoc Biol       Date:  2017-12       Impact factor: 4.962

6.  NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.

Authors:  Nikki B Marshall; Allen M Vong; Priyadharshini Devarajan; Matthew D Brauner; Yi Kuang; Ribhu Nayar; Elizabeth A Schutten; Catherine H Castonguay; Leslie J Berg; Stephen L Nutt; Susan L Swain
Journal:  J Immunol       Date:  2016-12-28       Impact factor: 5.422

7.  Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.

Authors:  Aimee Merino; Bin Zhang; Philip Dougherty; Xianghua Luo; Jinhua Wang; Bruce R Blazar; Jeffrey S Miller; Frank Cichocki
Journal:  J Clin Invest       Date:  2019-06-18       Impact factor: 14.808

8.  Role of the Immune Microenvironment in SARS-CoV-2 Infection.

Authors:  Chih-Hung Ye; Wen-Lin Hsu; Guan-Ru Peng; Wei-Chieh Yu; Wei-Chen Lin; SuiYun Hu; Shu-Han Yu
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 9.  Unraveling exhaustion in adaptive and conventional NK cells.

Authors:  Aimee M Merino; Hansol Kim; Jeffrey S Miller; Frank Cichocki
Journal:  J Leukoc Biol       Date:  2020-07-29       Impact factor: 4.962

10.  The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice.

Authors:  Norman Shreeve; Delphine Depierreux; Delia Hawkes; James A Traherne; Ulla Sovio; Oisin Huhn; Jyothi Jayaraman; Amir Horowitz; Hormas Ghadially; John R B Perry; Ashley Moffett; John G Sled; Andrew M Sharkey; Francesco Colucci
Journal:  Immunity       Date:  2021-04-21       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.